 |
| | Business Summary: Guided Therapeutics, Inc., a medical technology company, together with its subsidiaries, develops and offers products for the non-invasive cervical cancer detection and diabetes markets. | | | Address
5835 Peachtree Corners East, Suite D
Norcross
, GA 30092
Phone: 770-242-8723
Fax: 770-242-8639
Website: http://www.guidedinc.com
| | | Transfer Agent |
|---|
SunTrust Bank
| Employees: 17
ShareHolders: 151 | Founded: 1992
Domicile: Delaware | | | |
| | Guided Therapeutics, Inc., a medical technology company, together with its subsidiaries, develops and offers products for the non-invasive cervical cancer detection and diabetes markets. The company is developing a non-invasive cervical cancer detection product using its biophotonic technologies, which could be used to identify cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected or emanating from the cervix to produce a map or image of diseased tissue. Guided Therapeutics has an agreement with Konica Minolta Opto Inc. for the development of LightTouch prototype devices for the esophageal cancer detection application, as well as license agreements with Georgia Tech Research Corporation. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics was founded in 1992 and is based in Norcross, Georgia. | | History: INCORPORATED in Delaware Oct. 27, 1992. Name changed from SpectRx, Inc. to Guided Therapeutics, Inc. May 7, 2008. | | | | Subsidiaries: |
|---|
Guided
Therapeutics, Inc.
Sterling Medivations, Inc.
| | | | | | Capital Expenditures, thousand. US Dollars |
|---|
| Year | Amount | | 2009 | 0 |
| | | | | | Research and Development Expenditures, thousand. US Dollars |
|---|
| Year | Amount | | 2009 | 1,409 |
| | | | | |
|
Management
|
|---|
| Officers | Position |
|---|
| William E. Zachary, Jr. | Chairman | | Mark L. Faupel | President, Chief Operating Officer, Chief Financial Officer, Chief Accounting Officer & Chief Executive Officer | | Richard L. Fowler | Secretary & SR VP |
| | Directors |
|---|
| Ronald W. Allen | | Mark L. Faupel | | Ronald W. Hart | | John E. Imhoff | | Michael C. James | | Jonathan M. Niloff | | William E. Zachary, Jr. | | | |
| | | | Capitalization as of 03/31/2010: | | | | | Authorized Shares | Outstanding Shares |
|---|
| Preferred $0.001 par | 5,000,000 | None | | Common $0.001 par | 100,000,000 | 42,138,000so2 |
| | | | LONG TERM DEBT: None. | | | | Common $0.001 par | | | |
Stockholders:
02/25/2010,
151.
| |
Transfer Agent: SunTrust Bank
Atlanta
, GA | | | | OTC Bulletin Board( Primary): GTHP | | | | Exchange | Year | High | Low |
|---|
| OTC Bulletin Board | 2010 | 0.0000 | 0.0000 | | Over The Counter | 2009 | 1.7000 | 0.1500 | | Over The Counter | 2008 | 1.0500 | 0.1100 | | Over The Counter | 2007 | 0.7500 | 0.1900 | | OTC Bulletin Board | 2006 | 1.5500 | 0.1850 | | OTC Bulletin Board | 2005 | 0.7000 | 0.1700 | | OTC Bulletin Board | 2004 | 2.3500 | 0.3100 | | OTC Bulletin Board | 2003 | 3.9600 | 0.6500 | | NASDAQ Small Cap | 2002 | 7.1800 | 1.0200 | | NASDAQ National Market | 2001 | 10.2500 | 5.0450 |
|
| | | | DIVIDENDS: Common $0.001 par: None. | | | | | |
so2Excl. 46,000 in treas. | |
| | Annual Report |
|---|
| | | Income Statement | |
| 2009 | 2008 |
|---|
| REVENUES |
|
| | Service Revenues | 1,550 | 1,317 | | EXPENSES |
|
| | Sales and Marketing | (63) | (42) | | General and Administrative | (1,938) | (2,282) | | Research and Development | (1,409) | (2,060) | | Interest Expense | (3,983) | (1,891) | | Loss from Extinguishment of Debt, Net | (401) | - | | Other Income/expense | 32 | 148 | | Earnings before Taxes | (6,212) | (4,810) | | TAXES AND OTHER EXPENSES |
|
| | Net Income (Loss) | (6,212) | (4,810) | | CHARGES ON NET INCOME |
|
| | Dividends on Preferred Stock | (223) | (274) | | Net Income Available to Common Shareholders | (6,435) | (5,084) | | SUPPLEMENTARY INFO |
|
| | Operating Income (Loss) | (1,860.00) | (3,067.00) | | Basic EPS - Continuing Operations | (0.38) | (0.35) |
| | | | Balance Sheet | |
| 2009 | 2008 |
|---|
| CURRENT ASSETS |
|
| | Cash and Cash Equivalents | 230 | 68 | | Accounts Receivables | 132 | 164 | | Other Current Assets | 48 | 46 | | Total Current Assets | 410 | 278 | | NON CURRENT ASSETS |
|
| | Property and Equipment, net | 4 | 11 | | Capitalized Cost of Internally Developed Software for Internal Use | 113 | 23 | | Deferred Debt Issuance Costs, Net | 101 | 512 | | Other Assets | 161 | 51 | | Total Assets | 789 | 875 | | CURRENT LIABILITIES |
|
| | Accounts Payable | 1,158 | 1,337 | | Accrued Liabilities | 831 | 794 | | Notes Payable | 74 | 75 | | Notes Payable-past Due | 438 | 581 | | Convertible Notes Payable | 8,189 | 3,583 | | Deferred Revenue | 250 | 167 | | Dividends Payable-seriesa | 1,824 | 1,600 | | Advance Payable-roche | - | 381 | | Total Current Liabilities | 12,764 | 8,518 | | NON CURRENT LIABILITIES |
|
| | Minority Interest | 104 | - | | Preferred Stock Convertible | 1,962 | 3,069 | | SHAREHOLDERS' EQUITY |
|
| | Common Stock - Par Value | 20 | 16 | | Additional Paid in Capital | 61,642 | 58,784 | | Treasury Stock - Common | (104) | (104) | | Accumulated Deficit | (75,599) | (69,408) | | Total Shareholders Equity | (12,079) | (7,643) | | Total Liabilities & Shareholders Equity | 789 | 875 |
| | | |
| | Interim Report
|
|---|
| | | Data Not Available | | | | | | | | | |
| | Pro Forma Report
|
|---|
| | | Data Not Available | | | | | | | | | |
| | Quarterly Report Information
|
|---|
| | | Quarterly Revenue, US$ |
|---|
| Year | Quarter | Revenue | | 2010 |
1 | 820,000 | | 2009 |
1 | 180,000 | | 2009 |
2 | 240,000 | | 2009 |
3 | 580,000 | | 2009 |
4 | 550,000 | | 2009 |
Full Year
| 1,550,000 | | 2008 |
1 | 320,000 | | 2008 |
2 | 450,000 | | 2008 |
3 | 340,000 | | 2008 |
4 | 200,000 | | 2008 |
Full Year
| 1,320,000 | | 2007 |
1 | 250,000 | | 2007 |
2 | 250,000 | | 2007 |
3 | 200,000 | | 2007 |
4 | 340,000 | | 2007 |
Full Year
| 1,040,000 | | 2006 |
1 | 130,000 | | 2006 |
2 | 210,000 | | 2006 |
3 | 460,000 | | 2006 |
4 | 190,000 | | 2006 |
Full Year
| 980,000 | | 2005 |
1 | 370,000 | | 2005 |
2 | 270,000 | | 2005 |
3 | 170,000 | | 2005 |
4 | 170,000 | | 2005 |
Full Year
| 980,000 |
| | | | | | Quarterly Net Income, US$ |
|---|
| Year | Quarter | Revenue | | 2010 |
1 | (1,470,000) | | 2009 |
2 | (1,390,000) | | 2009 |
3 | (2,070,000) | | 2009 |
4 | (1,440,000) | | 2009 |
Full Year
| (6,210,000) | | 2008 |
1 | (780,000) | | 2008 |
2 | (1,200,000) | | 2008 |
3 | (1,590,000) | | 2008 |
4 | (1,240,000) | | 2008 |
Full Year
| (4,810,000) | | 2007 |
1 | (1,150,000) | | 2007 |
2 | (1,150,000) | | 2007 |
3 | (2,280,000) | | 2007 |
4 | (790,000) | | 2007 |
Full Year
| 1,230,000 | | 2006 |
1 | (1,190,000) | | 2006 |
2 | (1,530,000) | | 2006 |
3 | (1,110,000) | | 2006 |
Full Year
| (4,948,000) | | 2005 |
1 | (1,240,000) | | 2005 |
2 | (1,250,000) | | 2005 |
3 | (1,090,000) | | 2005 |
4 | 1,510,000 | | 2005 |
Full Year
| (2,070,000) |
| | | | | | Quarterly EPS, US$ |
|---|
| Year | Quarter | Revenue | | 2010 |
1 | (.15) | | 2009 |
1 | (.09) | | 2009 |
2 | (.09) | | 2009 |
3 | (.12) | | 2009 |
4 | (.08) | | 2009 |
Full Year
| (.38) | | 2008 |
1 | (.06) | | 2008 |
2 | (.09) | | 2008 |
3 | (.11) | | 2008 |
4 | (.08) | | 2008 |
Full Year
| (.35) | | 2007 |
1 | (.43) | | 2007 |
2 | (.43) | | 2007 |
3 | (.10) | | 2007 |
4 | (.06) | | 2007 |
Full Year
| (.23) | | 2006 |
1 | (.11) | | 2006 |
2 | (.14) | | 2006 |
3 | (.10) | | 2006 |
4 | (.10) | | 2006 |
Full Year
| (.45) | | 2005 |
1 | (.12) | | 2005 |
2 | (.12) | | 2005 |
3 | (.11) | | 2005 |
4 | .12 | | 2005 |
Full Year
| (.22) |
| | | |
| |
|
